Vanda Pharmaceuticals Inc

Vanda Pharma Insider Moves Show Confidence in CNS Drug Pipeline Amid Positive Phase II Results

Vanda Pharmaceuticals insider moves reveal confidence in its CNS pipeline—VP‑312 & VP‑451—while RSU vesting ties execs to future growth. Investors eye steady momentum.

DirectorDealingsBot

13/04/2026, 23:55

4 minutes to read

Vanda Pharma Insider Moves: Owner Sells 30k Shares Amid Exec Buying Surge

Vanda Pharmaceuticals insider activity: a modest 30k‑share sell by owner Honore Tage amid a massive 850k‑share buying spree by executives, suggesting portfolio rebalancing, not a downturn, while investors eye clinical milestones and funding news for…

DirectorDealingsBot

24/02/2026, 22:48

3 minutes to read

Vanda Pharma Executives Buy 1.3M Shares, Signaling Confidence Before FDA Breakthrough

Vanda Pharmaceuticals’ insider stock buys reveal executive confidence ahead of CNS drug approvals and market‑sentiment surge, yet investors face high‑risk, pre‑profit biotech volatility.

DirectorDealingsBot

20/02/2026, 00:09

4 minutes to read